, Tracking Stock Market Picks
Enter Symbol:
Repros Therapeutics Inc. (RPRX) [hlAlert]

down 40.19 %

Repros Therapeutics Inc. (RPRX) rated Buy by Lazard

Posted on: Tuesday,  Feb 5, 2013  8:25 AM ET by Lazard

Lazard rated Buy Repros Therapeutics Inc. (NASDAQ: RPRX) on 02/05/2013, when the stock price was $12.04. Since
then, Repros Therapeutics Inc. has lost 40.20% as of 01/14/2016's recent price of $7.20.
If you would have followed this Lazard's recommendation on RPRX, you would have lost 40.19% of your investment in 1073 days.

Repros Therapeutics Inc. (RPRX) is a development-stage biopharmaceutical company focused on the development of oral small molecule drugs for unmet medical needs. The Company's principal drug, Proellex, is a selective blocker of the progesterone receptor and is being developed for the treatment of uterine fibroids, anemia associated with excessive menstrual bleeding relating to uterine fibroids, or anemia associated with uterine fibroids and endometriosis. The second product candidate, Androxal, is a single isomer of clomiphene citrate and an orally active small molecule compound.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/5/2013 8:25 AM Buy
as of 12/13/2013
1 Week up  0.82 %
1 Month up  17.59 %
3 Months down  -24.18 %
1 YTD up  42.69 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy